Clinical trial
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity…
NCT00395135 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00395135 |
|---|---|
| Title | BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management |
| Official title | BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management; A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Lorcaserin 10 mg BID, Matching Placebo BID |
| Enrollment | 3,182 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Nov 2, 2006 |
| Last update posted | Oct 2, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: